Cell Medica receives £1.95 million to commercialise cell therapy

Cell Medica Ltd, an early-stage cellular therapeutics company, has received £1.95 million in new funding in order to commercialise its lead product, a cell therapy technique which protects patients from infection following a bone marrow transplant.

Location